EFFECT OF 5-LIPOXYGENASE INHIBITOR, VIA-2291, ON EPICARDIAL FAT VOLUME IN PATIENTS WITH RECENT ACUTE CORONARY SYNDROME

被引：0
|
作者：
Almeida, Shone [1 ]
Budhoff, Matthew [1 ]
机构：
[1] Los Angeles Biomed Res Inst, Torrance, CA USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2018年 / 71卷 / 11期
关键词：
D O I：
10.1016/S0735-1097(18)32134-X
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A1593
引用
收藏
页码：1593 / 1593
页数：1
相关论文
共 50 条
  • [41] Myocardial protection by intravenous 5-lipoxygenase inhibitor quercetin in patients with acute myocardial infarction: Short- and long-term results an open blind randomized trial
    Kovalenko, Vladimir
    Parkhomenko, A.
    Kozhukhov, S.
    CARDIOVASCULAR DRUGS AND THERAPY, 2007, 21 : S19 - S19
  • [42] Noninvasive evaluation of single-dose intravenous 5-lipoxygenase inhibitor effect on ventricular repolarization variability in patients with mild-to-moderate chronic heart failure
    Kozhukhov, S.
    Parkhomenko, A.
    Sosnytskyy, V.
    Dovganych, N.
    Sosnytska, T.
    EUROPEAN HEART JOURNAL, 2018, 39 : 983 - 983
  • [43] Myocardial protection by intravenous 5-lipoxygenase inhibitor quercetin administration before primary angioplasty in patients with acute myocardial infarction: Short-term results an open blind randomized trial
    Kozhukhov, Sergey
    Parkhomenko, Alexander
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (09) : 226A - 226A
  • [44] Initial Clinical Experience and PK/PD Relationships With AZD5718, a Novel Once Daily Oral 5-lipoxygenase Activating Protein (FLAP) Inhibitor, Intended for Patients With Coronary Arterial Disease
    Ericsson, Hans
    Nelander, Karin
    Lagerstrom-Fermer, Maria
    Balendran, Clare
    Forsberg, Gun-Britt
    Bhat, Maria
    Chialda, Ligia
    Gan, Li-Ming
    Heijer, Maria
    Kjaer, Magnus
    Lambert, John
    Lindstedt, Eva-Lotte
    Whatling, Carl
    Skrtic, Stanko
    CIRCULATION, 2017, 136
  • [45] Effect of the Clopidogrel-Proton Pump Inhibitor Drug Interaction on Adverse Cardiovascular Events in Patients with Acute Coronary Syndrome
    Bhurke, Sharvari M.
    Martin, Bradley C.
    Li, Chenghui
    Franks, Amy M.
    Bursac, Zoran
    Said, Qayyim
    PHARMACOTHERAPY, 2012, 32 (09): : 809 - 818
  • [46] Does Insurance Effect the Outcome in Patients With Acute Coronary Syndrome?: An Insight from the Most Recent National Inpatient Sample
    Chakraborty, Sandipan
    Bandyopadhyay, Dhrubajyoti
    Amgai, Birendra
    Sidhu, Jasdeep Singh
    Paudel, Rabin
    Koirala, Soniya
    Hajra, Adrija
    Ghosh, Raktim K.
    Lavie, Carl J.
    CURRENT PROBLEMS IN CARDIOLOGY, 2021, 46 (01)
  • [47] Effect of Alirocumab in Patients With Recent Acute Coronary Syndrome According to Renal Function: A Prespecified Analysis of the ODYSSEY OUTCOMES Trial
    Tunon, Jose
    Steg, Philippe G.
    Bhatt, Deepak L.
    Bittner, Vera A.
    Diaz, Rafael
    Goodman, Shaun G.
    Jukema, J. Wouter
    Kim, Yong-Un
    Li, Qian H.
    Mueller, Christian
    Parkhomenko, Alexander
    Pordy, Robert
    Sritara, Piyamitr
    Szarek, Michael
    White, Harvey D.
    Zeiher, Andreas M.
    Schwartz, Gregory G.
    CIRCULATION, 2019, 140
  • [48] Effect of selective BET protein inhibitor apabetalone on cardiovascular outcomes in patients with acute coronary syndrome and diabetes: Rationale, design, and baseline characteristics of the BETonMACE trial
    Ray, Kausik K.
    Nicholls, Stephen J.
    Ginsberg, Henry D.
    Johansson, Jan O.
    Kalantar-Zadeh, Kamyar
    Kulikowski, Ewelina
    Toth, Peter P.
    Wong, Norman
    Cummings, Jeffrey L.
    Sweeney, Michael
    Schwartz, Gregory G.
    AMERICAN HEART JOURNAL, 2019, 217 : 72 - 83
  • [49] Effect of Intensive Personalized "5As+5Rs" Intervention on Smoking Cessation in Hospitalized Acute Coronary Syndrome Patients Not Ready to Quit Immediately: A Randomized Controlled Trial
    Luo, Jing-guang
    Han, Ling
    Chen, Li-wei
    Gao, Yun
    Ding, Xiao-jun
    Li, Ying
    Ja, Ye
    Yang, Ming
    Ma, Chang-sheng
    NICOTINE & TOBACCO RESEARCH, 2018, 20 (05) : 596 - 605
  • [50] Effect of Apabetalone Added to Standard Therapy on Major Adverse Cardiovascular Events in Patients With Recent Acute Coronary Syndrome and Type 2 Diabetes A Randomized Clinical Trial
    Ray, Kausik K.
    Nicholls, Stephen J.
    Buhr, Kevin A.
    Ginsberg, Henry N.
    Johansson, Jan O.
    Kalantar-Zadeh, Kamyar
    Kulikowski, Ewelina
    Toth, Peter P.
    Wong, Norman
    Sweeney, Michael
    Schwartz, Gregory G.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (16): : 1565 - 1573
12345